Dergiler / Journal of Health Sciences and Medicine / 2022 / Cilt: 5 - Sayı: 3

Is there an association between thyroid function tests and 18F FDG PET/CT parameters in untreated cancer patients?

Sayfa
893–900
Yayın Tarihi
2022-05-30
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Age was found to be an independent prognostic factor in predicting mortality.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: We aimed to investigate the association between the extent of disease, 18F FDG PET/CT parameters (SUVmax and the highest SUVmax) and thyroid function tests (TFT) (TSH, FT4, FT3, FT3/FT4 ratio, AntiTG, and AntiTPO) in untreated cancer patients.
📊
Temel Bulgular & Veri:Material and Method: One hundred and seventy-nine patients who underwent FDG PET/CT for metabolic characterization and staging in our clinic between May 2020 and November 2020 were included in the study.
💡
Sonuç & Katkı:Age was found to be an independent prognostic factor in predicting mortality.
🔬Tür:Araştırma Makalesi
📍Kapsam:2020 Verileri
⚙️Değişkenler:PET/CT · SUVmax · thyroid hormones

Abstract

Objectives: We aimed to investigate the association between the extent of disease, 18F FDG PET/CT parameters (SUVmax and the highest SUVmax) and thyroid function tests (TFT) (TSH, FT4, FT3, FT3/FT4 ratio, AntiTG, and AntiTPO) in untreated cancer patients. Material and Method: One hundred and seventy-nine patients who underwent FDG PET/CT for metabolic characterization and staging in our clinic between May 2020 and November 2020 were included in the study. Patients were divided into two groups as malignant and benign according to histopathology findings. Thyroid function tests were ordered from all patients at the time of PET/CT imaging. The association between the presence of local lymph node metastasis, distant metastases and thyroid function tests as well as the association between PET/CT parameters and thyroid function tests in benign and malignant groups were statistically analyzed. Results: Thyroid function tests did not exhibit a significant difference between patients with malignant and benign disease (p> 0.05). Univariate logistic regression analysis revealed that age, FT4 value, and the FT3/F4 ratio were significant parameters in predicting distant metastases. These parameters were also significant in predicting mortality. Multivariate logistic regression analysis showed that age was an independent prognostic factor predicting mortality. Conclusion: Thyroid function tests are not decisive in differentiating malignant and benign lesions. While no statistically significant correlation was observed between thyroid function tests and PET/CT parameters, univariate analyses revealed that especially FT4 and FT3/FT4 ratio were significant in predicting disease extent and mortality in malignant disease. Age was found to be an independent prognostic factor in predicting mortality.

🔖

Bu Makaleye Atıf Yap

KAPLAN, İ., CAN, C., KÖMEK, H., KEPENEK, F., SOYLU, H., ERDUR, E., AGÜLOĞLU, N., GÜNDOĞAN, C. (2022). Is there an association between thyroid function tests and 18F FDG PET/CT parameters in untreated cancer patients?. Journal of Health Sciences and Medicine, Cilt: 5 - Sayı: 3, 893–900. https://ajindex.com/articles/776564

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. St Germain DL, Galton VA, Hernandez A. Minireview: defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology 2009; 150: 1097-107.
  2. Khan SR, Chaker L, Ruiter R, et al. Thyroid function and cancer risk: the Rotterdam study. J Clin Endocrinol Metab 2016; 101: 5030-6.
  3. Hellevik AI, Asvold BO, Bjøro T, et al. Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev 2009; 18: 570-4.
  4. Dalamaga M, Lekka A, Karmaniolas K, et al. Is thyroid autoimmunity a risk factor for developing primary myelodysplastic syndrome? Cancer Causes Control 2008; 19: 371-8.
  5. Davis FB, Mousa SA, O'Connor L, et al. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 2004; 94: 1500-6.
  6. Bergh JJ, Lin HY, Lansing L, et al. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 2005; 146: 2864-71.
  7. Lin HY, Davis FB, Gordinier JK, Martino LJ, Davis PJ. Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. Am J Physiol 1999; 276: 1014-24.
  8. Lin HY, Su YF, Hsieh MT, et al. Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone. FASEB J 2013; 27: 3209-16.
  9. Tosovic A, Bondeson AG, Bondeson L, et al. T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study. BMC Cancer 2014; 14: 536. Journy NMY, Bernier MO, Doody MM, et al. Hyperthyroidism, hypothyroidism, and cause-specific mortality in a large cohort of women. Thyroid 2017; 27: 1001-10.
  10. Selvaraj N, Bobby Z, Sridhar MG. Is euthyroid sick syndrome a defensive mechanism against oxidative stress? Med Hypotheses 2008; 71: 404-5.
  11. Ganesan K, Wadud K. Euthyroid sick syndrome. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
  12. Kwee TC, Basu S, Saboury B, et al. A new dimension of FDG-PET interpretation: assessment of tumor biology. Eur J Nucl Med Mol Imaging 2011; 38: 1158-70.
  13. El-Galaly TC, Gormsen LC, Hutchings M. PET/CT for staging; past, present, and future. Semin Nucl Med 2018; 48: 4-16.
  14. Ma CL, Li XD, Sun XR, et al. Using 18F-fluorodeoxyglucose positron emission tomography/ computed tomography to estimate the length of gross tumor and involvement of lymph nodes in esophagogastric junction carcinoma. J Cancer Res Ther 2018; 14: 896-90